How harmful is lymphoma

Once lymphoma reaches the level of malignancy, the harm it causes to people's health must be extremely serious. The common harmful manifestations of malignant lymphoma are something that people need to know in a timely manner so that they can pay enough attention to the lymphoma disease. So how serious are the harms of lymphoma?

The main harm of malignant lymphoma is that at present, there is an average of one new patient every 9 minutes in the world. The incidence of lymphoma in my country is 0.02 per thousand. There are about 25,000 new patients and nearly 20,000 deaths each year. The threat of lymphoma is rapidly emerging. It can be said that there are now a total of 350,000 people in the world who are affected by lymphoma. Usually, lymphoma occurs in young and middle-aged people, so it also has a certain impact on the labor force of today's society. Since the number of deaths caused by lymphoma exceeds 200,000, it can be seen that the harm of lymphoma is very great.
The specific hazards of malignant lymphoma for lymphoma metastasis: malignant lymphoma metastasis to the liver and spleen can cause hepatosplenomegaly, gastrointestinal metastasis has abdominal pain, abdominal distension, intestinal obstruction and bleeding, the lungs and pleura are common metastasis sites of advanced malignant lymphoma, causing cough and pleural effusion, malignant lymphoma bone metastasis can trigger a series of bone events, such as bone pain, pathological fractures, etc., skin metastasis causes skin itching and subcutaneous nodules, malignant lymphoma metastasis to the tonsils and mouth, nose, and pharynx causes dysphagia, nasal congestion, and nasal knots. In addition, malignant lymphoma nervous system metastasis can cause spinal cord compression, cranial neuropathies, etc.

Malignant lymphoma is harmful to health. Symptoms of advanced lymphoma. The systemic symptoms of malignant lymphoma vary greatly depending on the type of disease and the stage in which it occurs. Some patients may have no systemic symptoms. Fever, weight loss (weight loss of more than 10%), night sweats, etc. are more common in patients with symptoms, followed by loss of appetite, fatigue, itching, etc. Systemic symptoms are related to the age of onset, tumor range, and body immunity. Elderly patients, those with poor immune function or multifocal onset have significant systemic symptoms. The survival rate of patients without systemic symptoms is 3 times higher than that of those with symptoms.